Spherical Nucleic Acid Nanoparticle Screening via Machine Learning
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The complexity of spherical nucleic acids (SNAs) has hindered the development of effective nanomedicines due to the lack of high-throughput methods for synthesis and analysis, limiting the exploration of their structural changes and biological activity.
Innovation Solution
A method for rapid synthesis of SNA libraries and a mass spectrometry-based screening protocol to determine enzyme activation, enabling the optimization of SNA-based therapeutics by systematically varying multiple structural parameters and using machine learning to model enzyme activation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If traditional methods are used to study SNA structural changes and biological activity, then research can be conducted, but the process is slow and low-throughput due to SNA complexity
Solution Approach 1:
The patent segments the complex SNA structure into distinct modular components: nanoparticle core, oligonucleotide shell, and cargo payload. Each component can be independently varied and optimized. The screening process is also segmented into separate assays for different biological activities (cellular uptake, immune activation, cargo delivery), allowing high-throughput evaluation of individual parameters without requiring complete structural analysis of each SNA variant.
Solution Approach 2:
The patent systematically varies multiple parameters including nanoparticle core size (20-200 nm), oligonucleotide sequence (CpG motifs, length, composition), shell density, and cargo type. By changing these parameters in a controlled manner and measuring their individual effects on biological activity, the patent achieves high-throughput screening despite SNA complexity. Machine learning models are used to analyze the parameter-activity relationships and predict optimal SNA designs.
2Reliability
If comprehensive screening of SNA libraries is performed to identify optimal structures, then therapeutic efficacy can be optimized, but the number of nanoparticles required for testing becomes prohibitively large
Solution Approach 1:
The patent develops a universal screening platform that can evaluate multiple biological activities using a single SNA library. The same SNA variants are tested across different assay types (cellular uptake, immune activation, cargo delivery) to identify structures that excel in multiple functions simultaneously. This multi-functional approach reduces the total number of SNAs needed compared to separate specialized screens for each activity.
Solution Approach 2:
The patent uses computational modeling and machine learning to create virtual copies of SNA structures and predict their biological activity. These in silico models are trained on experimental data from a limited set of synthesized SNAs, then used to screen vast numbers of virtual SNA variants. This computational copying approach identifies promising candidates that are then synthesized and tested experimentally, dramatically reducing the number of physical nanoparticles required for comprehensive screening.
3Loss of information
If structural parameters of SNAs are systematically varied to explore design space, then structure-activity relationships can be established, but the synthesis and analysis process becomes increasingly complex
Solution Approach 1:
The patent introduces machine learning models as an intermediary between SNA synthesis and biological testing. These models learn the structure-activity relationships from experimental data and can predict the activity of new SNA designs before synthesis. This intermediary computational layer reduces the need for exhaustive experimental testing of all possible structural variations, simplifying the overall process while maintaining comprehensive coverage of the design space.
Solution Approach 2:
The patent performs preliminary computational screening and prediction using machine learning models before actual SNA synthesis and testing. Virtual SNA libraries are generated and evaluated in silico to identify the most promising candidates for experimental validation. This preliminary computational action filters out unlikely candidates, reducing the complexity of subsequent experimental synthesis and analysis while ensuring that structure-activity relationships are thoroughly explored.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach identifies thousands of therapeutic candidate structures with significant activity differences, reducing the number of nanoparticles needed for testing by an order of magnitude while maintaining comprehensive screening, and can be generalized to other nanomedicines for therapeutic development.
Implementation Method 1
immobilizing the product and the substrate on a self-assembled monolayer (SAM) on a surface
Implementation Method 2
subjecting the immobilized substrate and product to mass spectrometry to produce a mass spectrum having a product signal and a substrate signal
Data Source
AI summary
The present disclosure provides methods for the rapid synthesis of large libraries of spherical nucleid acid (SNA) nanoparticles, their screening for activity, and a machine learning algorithm to analyze the data.